1Utz JP, Swensen SJ, Gertz MA . Pulmonary amyloidosis. The Mayo clinic experience from 1980 to 1993. Ann Intern Med ,1996,124:407-413.
2Roger SZ, Gamold MP ,Marta VO, et al. Head aug neek manifestations of amyloidosis. Otolaryngology, 2001,120:553-557.
3Kyle RA , Gerte MA. Primary systemic amyloidosis : clinical aug laboratory feature in 474 cases. Semin Hematol ,1995,32:45.
4Desikan KR, Dhodapkar MV, Hough A, et al. Incidence and impact of light chain associated (AL) amyloidoais on the prognceh of patients with multiple myeloma treated with autologoustransplantation. Leuk Lymphoma,1997,27:315-319.
5Guy CD, Jones CK. Abdominal fat pad aspiration biopsy for tissue confirmation of systemic amyloidosis, specificity, positive predictive and value ,and diagnosistic pitfalls. Diagn Cytopathol, 2001,24:181-185.
6Sezer JO,Eucker J, Schmid P,et al. New therapeutic approaches in primary systemic AL amyloidosis. Ann Hematol ,2000,79 : 1-6.
